Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

News

Introducing the first vocabulary and 'reader' for analysing video images

Two complementary studies introduce a standardised framework for measuring changes in cells and tissues over time and linking them to the biological processes taking place beneath the surface.

Team ATLAS sets out strategy to investigate cancer avoidance

Team ATLAS sets out their plans to build a cancer antibody atlas to investigate why some people avoid cancer, while others develop disease.

CAR T cell therapy targets key mutation in rare blood cancers

A new study shows that CAR T cells can be engineered to recognise a mutation found in some myeloproliferative neoplasms, selectively killing cancer-driving blood stem cells while sparing healthy blood cells in patient samples and laboratory models.

Switching on cancer’s viral alarm system

A new study identifies METTL3 as a potential RNA-level immune checkpoint in colorectal cancer, revealing how its inhibition can activate viral mimicry and tumour cell death.

Small RNA sequences act as a ‘volume control’ for inflammation

New study reveals how upstream open reading frames fine-tune production of TNF Receptor 1, limiting inflammatory responses and helping prevent tissue damage.

Professor Helen Byrne appointed co-director of new Modelling-Informed Medicine Centre (MiMeC)

The new research centre will develop computer models to advance disease understanding and accelerate drug discovery.

Professor Xin Lu and Professor Chi Van Dang join global Cancer Grand Challenges team taking on the cancer avoidance challenge

Team ATLAS, an interdisciplinary collaboration including two researchers from the Ludwig Institute for Cancer Research, has been awarded up to $25 million over approximately five years through Cancer Grand Challenges to investigate the biological basis of cancer avoidance.

Professor Xin Lu featured on EACR’s The Cancer Researcher podcast

Professor Xin Lu features on the EACR podcast The Cancer Researcher, discussing her research on p53, the ASPP family and cellular plasticity.

Registration open for Ludwig Conference on Alternative Nucleic Acid Conformations in Health and Disease

The Oxford branch of the Ludwig Institute for Cancer Research welcomes registration and abstract submission for an upcoming international conference

Melanoma cells switch survival strategies under stress

Ludwig study reveals how melanoma cells reprogramme themselves to survive harsh conditions

Professor Xin Lu and Professor Yang Shi elected as Foreign Members of China’s Top Scientific Academies

Two Oxford Ludwig Professors have been recognised for their globally important work in advancing cancer research

Professor Richard White awarded prestigious Academy of Medical Sciences Professorship

Richard White, Professor of Genetics at Ludwig Oxford, has been named an Academy of Medical Sciences Professor

Ludwig researchers awarded grant to uncover how food-derived DNA changes may drive cancer risk

Ludwig scientists have been awarded a four-year grant from the World Cancer Research Fund International to investigate whether modified DNA molecules in food could contribute to mutations that drive bowel cancer.

Ludwig Oxford welcomes Dr Manav Pathania

Ludwig Oxford is delighted to welcome Dr Manav Pathania as an Assistant Member of the Ludwig Institute for Cancer Research, Oxford Branch.

Ludwig researchers develop first map of human RNA modification enzymes in landmark study

Findings published in Nature Cell Biology reveal how pseudouridine-modifying enzymes shape RNA biology.

From mutation to malignancy: mapping early events in kidney cancer

A new study from the Ratcliffe group examines how distinct HIFα isoforms shape the way VHL mutations lead to kidney cancer.

Richard White honoured with Teaching Excellence Award

Richard White recognised in the 2025 Medical Sciences Division Teaching Excellence Awards

Cancer Grand Challenges team card for team Cancer Antibody Atlas showing images of Xin Lu with her lab team.

Ludwig Oxford Director shortlisted for prestigious global research initiative, Cancer Grand Challenges

With awards of up to £20m, Cancer Grand Challenges teams are empowered to rise above the traditional boundaries of geography and discipline to make the progress against cancer we urgently need.

Impaired liver clearance drives accumulation of circulating cell-free DNA in sepsis

Study mapping cell-free DNA reveals new insights into organ dysfunction and infection in sepsis.

Photo of the Old Road campus Research Building from the road. Shows a green science building. © University of Oxford Images / John Cairns Photography -- All rights reserved.

Discover the science behind the scenes at the Old Road Campus Research Building

The ORCRB will open to the public on 13th September as part of Oxford Open Doors.

Load More